Pfizer

Pfizer to sell global infusion therapy business to ICU Medical for $1 bn

07 Oct 2016

Pfizer to acquire part of AstraZeneca's antibiotics business

24 Aug 2016

Pfizer in advanced talks to buy cancer drug specialist Medivation for nearly $14 bn

22 Aug 2016

A successful deal  would be Pfizer’s biggest acquisition since it purchased biologic drug specialist Hospira Inc last year for about $17 billion

Pfizer acquires gene therapy developer Bamboo Therapeutics in a $645 mn deal

02 Aug 2016

Fresenius and Smiths Group emerge final bidders for Pfizer's infusion pumps business

08 Jun 2016

Delhi HC directs Pfizer to withdraw drug Medrol 6 months ahead of expiry

23 May 2016

Pfizer to buy Anacor Pharmaceuticals for $5.2 bn

16 May 2016

Pfizer blocks sale of lethal injections for executions

14 May 2016

Pfizer Inc, the largest US pharmaceutical company, yesterday said that it will block its drugs being used in lethal injections, effectively cutting off supply of the drug used by states for executions

Pfizer initiates buyout talks with cancer drug maker Medivation

04 May 2016

US drug giant Pfizer Inc has initiated talks with cancer drug maker Medivation Inc over a possible buyout, a move that could rival a $9.3-billion offer from Sanofi

Pfizer calls halt to $160bn merger with Allergan: report

06 Apr 2016

The decision comes after the US Treasury unveiled new rules that proposed to limit companies’ ability to participate in inversion transactions if they have been engaged in acquisitions within the past 36 months

New Treasury rules threaten Allergan-Pfizer merger

05 Apr 2016

The US Treasury Department has framed new rules to throttle ‘inversions’, in a move seen to be directly prompted by the proposed Allergan-Pfizer merger, which would create the world’s biggest drug firm

P&G follows Pfizer, Abbot, ends sale of cold remedy

15 Mar 2016

India bans Pfizer, Abbot cough syrups; shares tank

14 Mar 2016

The centre has banned Pfizer’s Corex and Abbot Laboratories’ Phensedyl after a panel of experts found the codeine-based drugs had ‘no therapeutic justification’ and were leading to addiction as well as smuggling

Allergen deal to help Pfizer save $35 bn in annual taxes: report

26 Feb 2016

The Pfizer-Allergen deal is the largest inversion ever, which would potentially lower the merged entity's annual tax bill by $35 billion in the United States

Pfizer explores sale of Hospira's infusion pump business for $2 bn

14 Jan 2016

US politicians unite to flay Pfizer-Allergan deal

24 Nov 2015

Democratic presidential front-runner Hillary Clinton said the deal would “leave US taxpayers holding the bag”, while her Republican rival Donald Trump called it “disgusting”

Pfizer to take over Allergan in historic $150-bn deal

23 Nov 2015

The deal, the largest ever in the healthcare sector, will make Pfizer the world’s biggest drug maker, but the tax-cutting ‘inversion’ move is sure to draw political ire

Pfizer said to be in $150-bn merger talks with Allergan

19 Nov 2015

Merger talks are being held between US pharmaceutical giant Pfizer and Irish drug maker Allergan Plc, to create a global pharmaceutical behemoth worth over $300 billion

Pfizer, Allergan mull largest pharma merger

29 Oct 2015

US drug giant Pfizer Inc and Irish pharmaceutical company Allergan Plc are weighing a merger plan, which would create the world’s largest drug company with a market cap of more than $300 billion

Pfizer sells Thane plant to Vidhi Research for Rs178 cr

23 Sep 2015

Sanofi, Pfizer, Abbott eye Mexican generic drug maker Rimsa

21 Sep 2015

Indian Patent Office rejects Pfizer's claim for arthritis drug patent

07 Sep 2015

The Indian Patent Office has rejected a patent application by pharma multinational Pfizer Inc for its rheumatoid arthritis drug `Tofacitinib’ for failing to prove its efficacy over its original version for which patent protection is ending

Pfizer, Sandoz to close Thane plants to consolidate operations

15 Jul 2015

Cellectis SA shares jumps on sale talks with Pfizer

01 Jun 2015

Pfizer is unnamed bidder for Swedish rare disease firm Orphan Biovitrum

02 May 2015

Pfizer’s interest in rare diseases first became evident in December 2009, when the company licensed the worldwide rights to taliglucerase alfa, a product that treats the genetic disorder Gaucher disease